Pharmaceutical

Roche wins first approval for subcutaneous Tecentriq

The subcutaneous Tecentriq has been approved in the UK for all indications that its intravenous counterpart has received approval.

Aug 30, 2023 - 20:00
Roche wins first approval for subcutaneous Tecentriq
The subcutaneous Tecentriq has been approved in the UK for all indications that its intravenous counterpart has received approval.
Read the original article

Tags:

Previous Article

Codagenix pursues RSV vaccine development amid unexpected challenges

Next Article

Signal: PureHealth UK expansion shows continued focus on healthcare in UAE

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more

STAT+: Pharmalittle: We are reading about Catalent conc...

Feb 9, 2024

Hipra’s Covid-19 booster gets EMA nod and enters an uncertain landscape

Hipra’s Covid-19 booster gets EMA nod and enters an unc...

Mar 31, 2023

Simcere Zaiming and TargetRx agree TGRX-326 commercial rights

Simcere Zaiming and TargetRx agree TGRX-326 commercial ...

Sep 4, 2024